Eupraxia Pharmaceuticals Financial Statements 2022-2024 | EPRX

Fifteen years of historical annual and quarterly income statements for Eupraxia Pharmaceuticals (EPRX).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM20232022
$0.00$0$0
$0.00$0$0
$0.00$0$0
$8.15$20.56$13.63
$5.10$7.28$3.99
$0.00$0$0
$0.00$0$0
$-13.25$-27.85$-17.62
$1.03$-1.08$-1.37
$-12.22$-28.93$-18.99
$0.00$0.04$0
$-12.22$-28.97$-18.99
$0.00$0$0
$-22.63$-28.97$-18.99
$0.00$0$0
$-22.46$-28.22$-18.49
$-13.17$-27.69$-17.47
$-13.25$-27.85$-17.62
$-0.81$-1.17$-0.96
$-0.81$-1.17$-0.96

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-31
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$3.97$4.18$0$0$3.79$2.27$0
$2.58$2.52$0$0$1.92$1.26$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$-6.56$-6.69$0$0$-5.71$-3.54$0
$0.49$0.54$0$0$-3.80$-0.42$0
$-6.07$-6.15$0$0$-9.51$-3.96$0
$-0.01$0.01$0$0$0$0$0
$-6.06$-6.16$0$0$-9.51$-3.96$0
$0$0$0$0$0$0$0
$-6.06$-6.16$-4.10$-6.31$-9.51$-3.96$0
$0$0$0.00$0.00$0$0$0
$-6.01$-6.04$-4.10$-6.31$-9.38$-3.90$0
$-6.51$-6.66$0$0$-5.67$-3.50$0
$-6.56$-6.69$0$0$-5.71$-3.54$0
$-0.17$-0.21$-0.17$-0.26$-0.43$-0.18$0
$-0.17$-0.21$-0.17$-0.26$-0.43$-0.18$0.00